dl-Fenfluramine inhibits ethanol-induced ascorbic acid release in rat striatum studied by microdialysis

Addiction Biology

Volumn 3, Issue 3, 1998, Pages 295-308

  Wu, Chun Fu ^a   Liu, Wen ^a   Liu, Jing ^a   Yeh, Chyon Hwa ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ASCORBIC ACID; CYPROHEPTADINE; FENFLURAMINE; FLUOXETINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; ELECTROCHEMICAL DETECTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

EID: 0031849590     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556219872100     Document Type: Article

References (69)

1. Imperato A, Di Chiara G. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 1986;239:219-28.
2. Yoshimoto K, McBride WJ, Lumeng L, Li TK. Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol 1991; 9:17-22.
3. Yamamura T, Hishida S, Hatake K, Taniguchi T, Ouchi H. Effects of methamphetamine and ethanol on learning and brain neurotransmitters in rats. Pharmacol Biochem Behav 1992;42:389-400.
4. Erickson CK, Graham DJ. The alteration of cortical and recticular acetylcholine release by ethanol in vivo. J Pharmacol Exp Ther 1973;185:583-93.
5. Carmichael FJ, Israel Y. Effects of ethanol on neurotransmitter release by rat brain cortical slices. J Pharmacol Exp Ther 1975;193:824-34.
6. Martin D, Swartzwelder HS. Ethanol inhibits release of excitatory amino acids from slices of hippocampus area CA1. Eur J Pharmacol 1992; 219:469-72.
7. Nie Z, Madamba SG, Siggins GR. Ethanol inhibits glutamatergic neurotransmission in nucleus accumbens neurons by multiple mechanisms. J Pharmacol Exp Ther 1994;271:1566-73.
8. Svensson L, Wu CP, Johannessen K, Engel JA. Effect of ethanol on ascorbate release in the nucleus accumbens and striatum of freely moving rats. Alcohol 1992;9:535-40.
9. Liu W, Wu CF, Liu J, Li Z. Ethanol increases ascorbic acid release in rat striatum and nucleus accumbens. Chinese Bull Drug Depend 1996;5: 156-8.
10. Oh C, Gardiner TV, Rebec GV. Blockade of both D1- and D2- dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum. Brain Res 1989;480:184-9.
11. Pierce RC, Rebec GV. Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via nondopaminergic mechanisms. J Neurosci 1993; 13:4272-80.
12. Wu CP. Possible role of glutamatergic neurotransmission in regulating ethanol-evoked brain ascorbate release. Neurosci Lett 1994;171:105-8.
13. Wilson RL, Wightman RM. Systemic and nigral application of amphetamine both cause an increase in extracellular concentration of ascorbate in the caudate nucleus of the rat. Brain Res 1985;339: 219-26.
14. Basse-Tomusk A, Rebec GV. Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum. Pharmacol Biochem Behav 1990;35:55-60.
15. Saponjic RM, Mueller K, Krug D, Kunko PM. The effects of haloperidol, scopolamine, and MK-801 on amphetamine-induced increases in ascorbic acid and uric acid as determined by voltammetry in vivo. Pharmacol Biochem Behav 1994;48:161-8.
16. Brazell MP, Mitchell SN, Joseph MH, Gray JA. Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen. Neuropharmacology 1990;29:1177-85.
17. Enrico P, Esposito G, Mura MA, et al. Effect of morphine on striatal dopamine metabolism and ascorbic acid and uric acid release in freely moving rats. Brain Res 1997;745:173-82.
18. 2 receptors increases behavioral activation and ascorbate release in the neostriatum of freely moving rats. Eur J Pharmacol 1990;191:295-302.
19. Bigelow JC, Brown DS, Wightman RM. γ-Aminobutyric acid stimulates the release of endogenous ascorbic acid from rat striatal tissue. J Neurochem 1984;42:412-19.
20. Crespi F, Keane PE. The effect of diazepam and RO15-1788 on extracellular ascorbic acid, DOPAC and 5-HIAA in striatum of anesthetized and conscious freely moving rats, as measured by differential pulse voltammetry. Neurosci Res 1987;4: 323-41.
21. Subramanian N. On the brain ascorbic acid and its importance in metabolism of biogenic amines. Life Sci 1977;20:1479-84.
22. Dayton MA, Ewing AG, Wightman RM. Evaluation of amphetamine-induced in vivo electrochemical response. Eur J Pharmacol 1981;75:141-4.
23. Wu CF, Liu W, Xu NJ, Liu J. Reserpine does not block ethanol-induced striatal ascorbate release in rats. Chinese J Neurosci 1995;Suppl.:33.
24. Chesselet MF. Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Neuroscience 1984;12:347-75.
25. Yadid G, Pacak K, Kopin IJ, Goldstein DS. Endogenous serotonin stimulates striatal dopamine release in conscious rats. J Pharmacol Exp Ther 1994;270:1158-65.
26. Blandina P, Goldfarb J, Craddock-Royal B, Green JP. Release of endogenous dopamine by stimulation of 5-hydroxytryptamine 3 receptors in rat striatum. J Pharmacol Exp Ther 1989;251:803-9.
27. 3 antagonist on drug-induced stimulation of dopamine release. Eur J Pharmacol 1989;164:515-19.
28. 3 receptors attenuates the effects of ethanol on extracellular dopamine. Eur J Pharmacol 1990; 187:287-9.
29. O'Neill RD, Fillenz M, Sundstrom L, Rawlins JNP. Voltammetrically monitored brain ascorbate as an index of excitatory amino acid release in the unrestrained rat. Neurosci Lett 1984;52:227-33.
30. Miele M, Boutelle MG, Fillenz M. The physiologically induced release of ascorbate in rat brain is dependent on impulse traffic, calcium influx and glutamate uptake. Neuroscience 1994;68:87-91.
31. Desole MS, Miele M, Enrico P. et al. Effects of cortical ablation on apomorphine- and scopolamine-induced change in dopamine turnover and ascorbic acid catabolism in the rat striatum. Eur J Pharmacol 1992;219:67-74.
32. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic press, 1982.
33. Consolo S, Wu CF, Fiorentini F, Ladinsky H, Vezzani A. Determination of endogenous acetylcholine release in freely moving rats by transstriatal dialysis coupled to a radioenzymatic assay: effect of drugs. J Neurochem 1987;48:1459-65.
34. Wu CF, Bertorelli R, Sacconi M, Pepeu G, Consolo S. Decrease of brain acetylcholine release in aging freely moving rats detected by microdialysis. Neurobiol Aging 1988;9:357-61.
35. Zetterstrom T, Sharp T, Marsden CA, Ungerstedt U. In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. J Neurochem 1983;41:1769-73.
36. Costa E, Groppetti A, Revuelta AJ. Action of fenfluramine on monoamine stores of rat tissue. Br J Pharmacol 1971;41:57-64.
37. Mennini T, Borroni E, Samanin R, Garattini S. Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin. Neurochem Int 1981;3:289-94.
38. Maura G, Gemigani A, Versace P, Martire M, Raiteri M. Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings. Neurochem Int 1982;4:219-24.
39. Sabol KE, Richards JB, Seiden LS. Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Res 1992;585:421-4.
40. McBride WJ, Aprison MH, Hingtgen JN. Effect of 5-hydroxytryptophan on serotonin in nerve endings. J Neurochem 1974;23:358-92.
41. Gartside SE, Cowen PJ, Sharp T. Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology 1992;31:9-14.
42. Fuller RW, Perry KW, Molloy BB. Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci 1974-15: 1161-71.
43. Wong DT, Bymaster FP, Horng JS, Molloy BB. A new selective inhibitor for uptake of serotonin into synptosomes of rat brain: 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. J Pharmacol Exp Ther 1975;193:804-11.
44. Perry KW, Fuller RW. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci 1992;50:1683-90.
45. Goudie AJ, Thornton EW, Wheeler TJ. Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia: evidence for serotoninergic inhibition of feeding. J Pharm Pharmacol 1976;28:318-20.
46. Alvarado RS, Contreras N, Seqouia-Riquelnie N, Mardones J. Effects of serotonin uptake blockers and of 5-hydroxytryptophan on the voluntary consumption of ethanol, water and solid food by UChA and UChB rats. Alcohol 1990;7:315-19.
47. Lu M-R, Wagner GC, Fisher H. Ethanol consumption following acute fenfluramine, fluoxetine, and dietary tryptophan. Pharmacol Biochem Behav 1993;44:931-7.
48. Rezvani AH, Grady DR. Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction. Pharmacol Biochem Behav 1994;48:105-10.
49. Zabik JE, Roache JD. 5-Hydroxytryptophan-induced conditioned taste aversion to ethanol in the rat. Pharmacol Biochem Behav 1983;18:785-90.
50. Rutter JJ, Auerbach SB. Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J Pharmacol Exp Ther 1993;265:1319-24.
51. Perry KW, Fuller RW. Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus L-5-hydroxytryptophan. J Pharm Pharmacol 1993;45:759-61.
52. McElroy JF, Feldman RS. Discriminative stimulus properties of fenfluramine: evidence for serotonergic involvement. Psychopharmacology 1984; 83:172-81.
53. Willner P, McGuirk J, Phillips G, Muscat R. Behavioural analysis of the anoretic effects of fluoxetine and fenfluramine. Psychopharmacology 1990;102: 273-7.
54. Richards JB, Sabol KE, Seiden LS. Fluoxetine prevents the disruptive effects of fenfluramine on differential reinforcement of low rate 72-second schedule performance. J Pharmacol Exp Ther 1993;267:1256-63.
55. Sugrue MF. Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake. Br J Pharmacol 1984;81:651-7.
56. Clineschmidt BV, McGuffin JC. Pharmacological differentiation of the central 5-hydroxytryptamine-like action of MK-212(6-chloro-2-[1-piperazinyl]-pyrazine), p-methoxyamphetamine and fenfluramine in an in vivo model system. Eur J Pharmacol 1978;50:369-75.
57. Fornal C, Radulovacki M. Sleep suppressant action of fenfluramine in rats II. Evidence against the involvement of presynaptic serotonergic mechanism. J Pharmacol Exp Ther 1982;225:675-81.
58. Carboni E, Di Chiara G. Serotonin release estimated by transcortical dialysis in freely moving rats. Neuroscience 1989;32:637-45.
59. Gobbi M, Frittoli E, Uslenghi A, Mennini T. Evidence of an exocytotic-like release of [ H]5-hydrotryptamine induced by d-fenfluramine in rat hippocampal synaptosomes. Eur J Pharmacol 1993; 238:9-17.
60. Raiteri M, Bonanno G, Vallebouna F. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. J Pharmacol Exp Ther 1995;273:643-9.
61. Clemens JA, Sawyer BD, Cerimele B. Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion. Endocrinology 1977;100:692-8.
62. Fuller RW, Owen JE. Suppression of milk drinking by the combination of fluoxetine and L-5-hydroxytryptophan in rats. Res Commun Chem Pathol Pharmacol 1981;34:137-40.
63. Yan QS, Jobe PC, Dailey JW. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsyprone rats. Eur J Pharmacol 1994;252:105-12.
64. Garattini S, Mennini T, Bendotti C, Invernizzi R, Samanin R. Neurochemical mechanism of action of drugs which modify feeding via the serotonergic system. Appetite 1986;7(Suppl.):15.
65. Wong DT, Bymaster FP, Reid LY, Threlkeld PG. Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors. Biochem Pharmacol 1985;32:1287-93.
66. 1C receptors and their therapeutic relevance. Curr Opin Invest Drugs 1993; 2:317.
67. Hoyer D, Clarke DE, Fozard JR, et al. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157-93.
68. Ni YG, Miledi R. Blockade of 5HT(2C) serotonin receptors by fluoxetine (Prozac). Proc Nat Acad Sci USA 1997;94:2036-40.
69. Engelman EA, Murphy JM, Zhou FC, Aprison MH, Hingtgen JN. Operant response suppression induced with systemic administration of 5-hydroxytryptophan is central mediated. Pharmacol Biochem Behav 1995;52:525-9.